Thank you for the opportunity to respond to Iwasaki and Gilbert. Though obesity was not a
risk factor for migraine in our study, we found that obese migraine
sufferers had more frequent, painful and disabling headaches than those
who were normal weighted. [1] In separate studies, we also showed that
obesity is a longitudinal risk factor for incident chronic daily headache
(headache > 15 days per month) and that the association of obesity with
transformed migraine is robust while the association of obesity with
chronic tension type headache is modest. [2,9]
Iwasaki and Gilbert both ask about the potential role of sleep
apnea in the exacerbation of migraine in obese subjects. Though we can
not directly test this hypothesis, obesity and snoring are independent
risk factors for chronic daily headache. [2] If snoring is a reasonable
proxy for sleep apnea, then the influence of obesity on migraine frequency
appears to be independent of sleep apnea. This is an excellent area for
further research.
Iwasaki and Ikeda also identify hyperlipidemia and mitochondrial
dysfunction as factors which may confound or contribute to the
relationship between migraine and obesity. Unfortunately, we do not have
the data to test these reasonable hypotheses. Obesity is a
proinflammatory state, associated with hyperlipidemia, hypertension and
insulin resistance in the metabolic syndrome. [10]. Additional research is
required to disentangle the contribution of these features, separately and
in combination, to the worsening of migraine and the emergence of chronic
daily headache.
Though we recently reviewed mitochondrial dysfunction in
migraine [11]), we do not know how this is connected with obesity. Nor do
we know if the duration of obesity contributes to migraine exacerbations
or if weight loss reduces headache frequency or severity.
The identification of factors that exacerbate migraine and contribute
to its progression is in its infancy. We look forward to finding more
satisfactory answers to the excellent questions raised in these letters.
References
1.Bigal ME, Liberman JN, Lipton RB. Obesity and migraine:A population study.Neurology 2006;66:545-550.
2.Scher AI, Stewart WF,Ricci JA, Lipton RB.Factors associated with the onset
and remission of chronic daily headache in a population-based study.Pain
2003;106:81-89.
3.Schoenen J. Deficient habituration of evoked cortical potentials in migraine:A link between biology,behavior and trigeminovascular activation? Biomed Pharmavother 1996;50:71-78.
4. Loh NK, Dinner DS, Foldvary N, Skobieranda F, Yew WW. Do patients with obstructive sleep apnea wake up with headaches? Ann Intern Med 1999;159:1765-1768.
5. Ulfberg J, Carter N, Talback M, and Edling C. Headache, snoring, and sleep apnea. J Neurol 1996; 243:621-625.
6. Gilbert GJ. The Purpose of Migraine. Quarterly J. FL Med. Assn 2005;26-27.
7. Silber E, Sonnenberg P, Collier DJ, Pollard AJ, Murdoch DR, Goadsby PI. Clinical features of headache at altitude. A prospective study. Neurology 2003;60:1167-1171.
8. Post MC, Thijs V, Schonewille WJ, Budts W, Snijder RJ, Plokker HWM, and Westermann CJJ. Embolization of pulmonary
arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006;66:202-205.
9. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine
but not chronic tension-type headache. Neurology 2006; 67: 252-257.
10. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J
Clin Invest. 2006;116:1793-801.
11. Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial
dysfunction and migraine: evidence and hypotheses. Cephalalgia. 2006;26:361-72.
Disclosure: Ortho-McNeil Neurologics funded the analysis of this study discussed in this Correspondence. Drs. Bigal and Lipton have received honoraria from Ortho-McNeil Neurologics unrelated to this study.